{"entity":{"id":"huang-xiaojun","kind":"person","name":"Xiaojun Huang","aka":["Huang Xiao-Jun","黄晓军"],"tldr":"Xiaojun Huang built the Beijing Protocol for stem cell transplants from half-matched family donors, which means almost every Chinese leukaemia patient can now find a donor.","summary":"Huang's group developed haploidentical transplantation without in vitro T-cell depletion using G-CSF-primed grafts and anti-thymocyte globulin (Bone Marrow Transplantation 2006), now the most common transplant type in China and increasingly used worldwide; his centre performs more haploidentical transplants than any other. Later work covers relapse prevention, GVHD and CAR-T bridging to transplant. Academician of the Chinese Academy of Engineering.","asOf":"2026-09-10","links":[{"label":"Peking University People's Hospital","url":"https://www.pkuph.cn/"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20XJ%5BAuthor%5D%20haploidentical%20Peking%20University"}],"tags":["china"],"related":[],"cancers":["aml","all-leukemia"],"sections":[],"technologies":["allogeneic-cell-therapy"],"targets":[],"drugs":[],"companies":[],"institutions":["pku-peoples-hospital"],"pathways":[],"terms":["allogeneic-transplant","gvhd"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director, Peking University Institute of Hematology; Peking University People's Hospital","institutionId":"pku-peoples-hospital","specialisms":["Haematopoietic stem cell transplantation","Haploidentical transplantation","Acute leukaemia","Graft-versus-host disease"],"profiles":[{"label":"Peking University People's Hospital","url":"https://www.pkuph.cn/"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20XJ%5BAuthor%5D%20haploidentical%20Peking%20University"}],"papers":[{"title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies","journal":"Bone Marrow Transplantation","year":2006,"doi":"10.1038/sj.bmt.1705445"}]},"route":"/people/huang-xiaojun/","neighbours":{"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"}],"technology":[{"id":"allogeneic-cell-therapy","kind":"technology","name":"Allogeneic (off-the-shelf) cell therapy","route":"/technologies/allogeneic-cell-therapy/"}],"institution":[{"id":"pku-peoples-hospital","kind":"institution","name":"Peking University People's Hospital","route":"/institutions/pku-peoples-hospital/"}],"term":[{"id":"allogeneic-transplant","kind":"term","name":"Allogeneic stem cell transplant (allo-SCT)","route":"/terms/allogeneic-transplant/"},{"id":"gvhd","kind":"term","name":"Graft-versus-host disease (GVHD) and graft-versus-leukaemia","route":"/terms/gvhd/"}]}}